Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-αl and interferon-α2a

This publication has 13 references indexed in Scilit:

• Immuno-chemotherapy of advanced colorectal cancer with alpha-2a interferon and 5-fluorouracil. Immunopharmacological studies
  Annals of Oncology, 1991
• A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: a Southwest Oncology Group study.
  Journal of Clinical Oncology, 1991
• Non-small cell lung cancer Part II: Treatment
  Current Problems in Cancer, 1991
• Combination treatment using thymosin α1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in mice
  Cancer Immunology, Immunotherapy, 1990
• Randomized Phase II-III Trial of Combination Beta and Gamma Interferons and Etoposide and Cisplatin in Inoperable Non-Small Cell Cancer of the Lung
  JNCI Journal of the National Cancer Institute, 1989
• Synergistic effect of thymosin α1 and αβ-interferon on NK activity in tumor-bearing mice
  International Journal of Immunopharmacology, 1989
• Pulmonary Natural Killer Cell Activity Is Reduced in Patients with Bronchogenic Carcinoma^1–3
  American Review of Respiratory Disease, 1987
• A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma.
  Journal of Clinical Oncology, 1986
• Enhancement of natural killer cell activity in mice by treatment with a thymic factor
  Cancer Immunology, Immunotherapy, 1984
• Reporting results of cancer treatment
  Cancer, 1981